Ethyl 2-(3,4-dimethoxyphenyl)acetate, 95.0%, 100g

(S)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(benzyloxy)-5-oxopentanoic acid, 97%, 10g

1,1,5,5-Tetrafluoropentane-2,4-dione, 97.0%, 25g

Methylimidazole, min 99%, for synthesis, 1L, glass packaging

Methylamine Acetate>97.0%(N)1g

3-BROMOQUINOLINE-6-CARBOXYLIC ACID, 95.0%, 1g

(5-Phenyl-1,3,4-oxadiazol-2-yl)methylamine, 95.0%, 1g

Methyl 3-methoxy-4-nitrobenzoate, 98.0%, 5g

6-bromo-5-methylimidazo[1,2-a]pyridine, 95.0%, 1g

N-((2S,3R,E)-1,3-dihydroxyoctadec-4-en-2-yl)butyramide, 98%, 25mg

5-BROMO-6-METHOXYQUINOLINE, 95.0%, 500mg

6-Chloro-N4-[3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-2,4-pyrimidinediamine, 100mg

5-HYDROXYPICOLINIC ACID HCL, 95.0%, 1g